Lv77
3349 积分 2020-04-21 加入
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
1天前
已完结
醛固酮受体拮抗剂对心肾保护作用的研究进展
2天前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2天前
已完结
Early Efficacy and Safety of Finerenone on Type 2 Diabetes‐Related Chronic Kidney Disease: A Real‐World Observational Study in China
3天前
已完结
Kidney Effects of Finerenone Added to Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease
3天前
已完结
Implementation of Established Global Guidelines in the Management of CKD in Patients with Type 2 Diabetes in Asia
4天前
已完结
Medical therapies for hypertrophic cardiomyopathy: Current state of the art
4天前
已完结
Apical Hypertrophic Cardiomyopathy: Diagnosis, Natural History, and Management
4天前
已完结
Cardiac Myosin Inhibitors: Expanding the Horizon for Hypertrophic Cardiomyopathy Management
4天前
已完结
Hypertrophic cardiomyopathy overview: Genetics, screening, and treatment
4天前
已完结
皖公网安备34019202002308
